JP2019512518A5 - - Google Patents

Download PDF

Info

Publication number
JP2019512518A5
JP2019512518A5 JP2018549457A JP2018549457A JP2019512518A5 JP 2019512518 A5 JP2019512518 A5 JP 2019512518A5 JP 2018549457 A JP2018549457 A JP 2018549457A JP 2018549457 A JP2018549457 A JP 2018549457A JP 2019512518 A5 JP2019512518 A5 JP 2019512518A5
Authority
JP
Japan
Prior art keywords
vaccine
pcv2
prrs virus
immunogen
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018549457A
Other languages
English (en)
Japanese (ja)
Other versions
JP7558638B2 (ja
JP2019512518A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/056781 external-priority patent/WO2017162720A1/en
Publication of JP2019512518A publication Critical patent/JP2019512518A/ja
Publication of JP2019512518A5 publication Critical patent/JP2019512518A5/ja
Application granted granted Critical
Publication of JP7558638B2 publication Critical patent/JP7558638B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018549457A 2016-03-23 2017-03-22 Pcv2およびprrsウイルス感染に対する皮内適用のためのワクチン Active JP7558638B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16161994 2016-03-23
EP16161994.5 2016-03-23
PCT/EP2017/056781 WO2017162720A1 (en) 2016-03-23 2017-03-22 A vaccine for intradermal application against pcv2 and prrs virus infection

Publications (3)

Publication Number Publication Date
JP2019512518A JP2019512518A (ja) 2019-05-16
JP2019512518A5 true JP2019512518A5 (enExample) 2020-03-12
JP7558638B2 JP7558638B2 (ja) 2024-10-01

Family

ID=55589753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018549457A Active JP7558638B2 (ja) 2016-03-23 2017-03-22 Pcv2およびprrsウイルス感染に対する皮内適用のためのワクチン

Country Status (7)

Country Link
US (1) US11654191B2 (enExample)
EP (1) EP3432920A1 (enExample)
JP (1) JP7558638B2 (enExample)
CN (1) CN108883169A (enExample)
BR (1) BR112018069219A2 (enExample)
RU (1) RU2746127C2 (enExample)
WO (1) WO2017162720A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108610424B (zh) * 2018-05-08 2021-07-27 重庆市畜牧科学院 一种重组蛋白及其在制备猪圆环病毒和猪繁殖与呼吸综合征病毒疫苗中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380376B1 (en) 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
JP2006528647A (ja) * 2003-07-24 2006-12-21 メリアル リミテッド 新規ワクチン製剤
ATE462445T1 (de) 2005-01-13 2010-04-15 Boehringer Ingelheim Vetmed Prrs-impfstoffe
DK1926496T3 (da) 2005-09-09 2013-09-30 Intervet Int Bv PCV-2-vaccine
DK2371383T3 (en) 2005-12-29 2015-11-30 Boehringer Ingelheim Vetmed Use of a PCV2 immunogenic composition for reduction of clinical symptoms in pigs
EP3320919B1 (en) 2005-12-29 2020-05-27 Boehringer Ingelheim Animal Health USA Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
AU2007333857B2 (en) 2006-12-15 2014-05-15 Boehringer Ingelheim Animal Health USA Inc. Treatment of pigs with PCV2 antigen
CA2712006A1 (en) * 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗
WO2011075379A1 (en) * 2009-12-18 2011-06-23 Boehringer Ingelheim Vetmedica, Inc. Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
US8728487B2 (en) 2011-01-20 2014-05-20 Hua Wu Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9457073B2 (en) 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
CN110354258A (zh) * 2013-12-03 2019-10-22 英特维特国际股份有限公司 抗猪圆环病毒2型的疫苗
WO2015082457A1 (en) 2013-12-03 2015-06-11 Intervet International B.V. Vaccine against lawsonia intracellularis and porcine circovirus 2
TWI670085B (zh) * 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
ES2785381T3 (es) * 2014-02-20 2020-10-06 Cma Macch Per Caffe Srl Máquina de café y procedimiento de control relacionado

Similar Documents

Publication Publication Date Title
JP2019509300A5 (enExample)
RU2018137034A (ru) Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae
PH12019500289A1 (en) Vaccines directed against a human enteroviruses
EP4218813A3 (en) High concentration anti-c5 antibody formulations
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
NZ597000A (en) Compositions and methods for administration of vaccines against dengue virus
JP2015520196A5 (enExample)
MX2020006662A (es) Vacuna combinada intradermica contra mycoplasma y circovirus porcino.
CA2646574A1 (en) Vaccine against mycoplasma and prrsv
WO2017156511A8 (en) Live attenuated zika virus vaccine
RU2021112503A (ru) Поливалентная вакцина против м. hyo и её применение
MX2022003090A (es) Vacuna combinada para ser administrable intradermicamente.
JP2023025210A5 (enExample)
DK3076997T3 (en) SVINEVACCINE v PRRS AND LAWSONIA INTRACELLULARIS
BR112016012435A8 (pt) vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
JP2019512518A5 (enExample)
NO20090290L (no) Polyvalent vaksine mot salmonid alfavirusinfeksjoner
BR112017006599A2 (pt) composição farmacêutica de vacina para administração transdérmica
RU2019136252A (ru) Вакцины, содержащие патогены свиней, для ассоциированного несмешанного применения
RU2008144180A (ru) Вакцина против микоплазмы и prrsv
RU2018137033A (ru) Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs
JP2019509302A5 (enExample)
RU2018137036A (ru) Комбинированная вакцина против инфекции вирусами pcv2 и prrs, содержащая альбумин
RU2022116197A (ru) Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae
MX2022013080A (es) Una combinacion de vacunas para el tratamiento profilactico de un cerdo.